Notably, myoblast cell sheets have already been used to successfully treat severe heart failure, demonstrating the potential of this technology. However, there are still a few unsolved challenges ...

Notably, myoblast cell sheets have already been used to successfully treat severe heart failure, demonstrating the potential of this technology. However, there are still a few unsolved challenges ...

The study results showed: BP1001-A reduced Grb2 protein expression in myoblast cells; BP1001-A increased the levels of phosphorylated AKT and phosphorylated FOXO-1 in myoblast and hepatoma cells in ...

For example, a clinical trial using myoblast cell sheets to treat heart failure has recently been completed. This success has allowed the release of the myoblast sheet as the world's first marketed ...

The findings indicated that BP1001-A reduced Grb2 protein expression in myoblast cells and enhanced insulin-induced metabolic activities in myoblast and hepatoma cells. These outcomes suggest that ...